27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.

Abstract:

:The cardioprotective effects of estrogen are mediated by receptors expressed in vascular cells. Here we show that 27-hydroxycholesterol (27HC), an abundant cholesterol metabolite that is elevated with hypercholesterolemia and found in atherosclerotic lesions, is a competitive antagonist of estrogen receptor action in the vasculature. 27HC inhibited both the transcription-mediated and the non-transcription-mediated estrogen-dependent production of nitric oxide by vascular cells, resulting in reduced estrogen-induced vasorelaxation of rat aorta. Furthermore, increasing 27HC levels in mice by diet-induced hypercholesterolemia, pharmacologic administration or genetic manipulation (by knocking out the gene encoding the catabolic enzyme CYP7B1) decreased estrogen-dependent expression of vascular nitric oxide synthase and repressed carotid artery reendothelialization. As well as antiestrogenic effects, there were proestrogenic actions of 27HC that were cell-type specific, indicating that 27HC functions as an endogenous selective estrogen receptor modulator (SERM). Taken together, these studies point to 27HC as a contributing factor in the loss of estrogen protection from vascular disease.

journal_name

Nat Med

journal_title

Nature medicine

authors

Umetani M,Domoto H,Gormley AK,Yuhanna IS,Cummins CL,Javitt NB,Korach KS,Shaul PW,Mangelsdorf DJ

doi

10.1038/nm1641

subject

Has Abstract

pub_date

2007-10-01 00:00:00

pages

1185-92

issue

10

eissn

1078-8956

issn

1546-170X

pii

nm1641

journal_volume

13

pub_type

杂志文章
  • Emerging interactions between skin stem cells and their niches.

    abstract::The skin protects mammals from insults, infection and dehydration and enables thermoregulation and sensory perception. Various skin-resident cells carry out these diverse functions. Constant turnover of cells and healing upon injury necessitate multiple reservoirs of stem cells. Thus, the skin provides a model for stu...

    journal_title:Nature medicine

    pub_type: 杂志文章,评审

    doi:10.1038/nm.3643

    authors: Hsu YC,Li L,Fuchs E

    更新日期:2014-08-01 00:00:00

  • Vitamin E decreases bone mass by stimulating osteoclast fusion.

    abstract::Bone homeostasis is maintained by the balance between osteoblastic bone formation and osteoclastic bone resorption. Osteoclasts are multinucleated cells that are formed by mononuclear preosteoclast fusion. Fat-soluble vitamins such as vitamin D are pivotal in maintaining skeletal integrity. However, the role of vitami...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm.2659

    authors: Fujita K,Iwasaki M,Ochi H,Fukuda T,Ma C,Miyamoto T,Takitani K,Negishi-Koga T,Sunamura S,Kodama T,Takayanagi H,Tamai H,Kato S,Arai H,Shinomiya K,Itoh H,Okawa A,Takeda S

    更新日期:2012-03-04 00:00:00

  • Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain.

    abstract::Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brai...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm.2749

    authors: Shichita T,Hasegawa E,Kimura A,Morita R,Sakaguchi R,Takada I,Sekiya T,Ooboshi H,Kitazono T,Yanagawa T,Ishii T,Takahashi H,Mori S,Nishibori M,Kuroda K,Akira S,Miyake K,Yoshimura A

    更新日期:2012-06-01 00:00:00

  • Natural regulatory T cells control the development of atherosclerosis in mice.

    abstract::Atherosclerosis is an immunoinflammatory disease elicited by accumulation of lipids in the artery wall and leads to myocardial infarction and stroke. Here, we show that naturally arising CD4(+)CD25(+) regulatory T cells, which actively maintain immunological tolerance to self and nonself antigens, are powerful inhibit...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1343

    authors: Ait-Oufella H,Salomon BL,Potteaux S,Robertson AK,Gourdy P,Zoll J,Merval R,Esposito B,Cohen JL,Fisson S,Flavell RA,Hansson GK,Klatzmann D,Tedgui A,Mallat Z

    更新日期:2006-02-01 00:00:00

  • Real-time quantitative RT-PCR after laser-assisted cell picking.

    abstract::The present study describes a technique for quantitation of mRNA in a few isotypic cells obtained from an intact organ structure by combining laser-assisted cell picking and real-time PCR. The microscopically controlled lasering of selected cells in stained tissue sections was applied to lung alveolar macrophages, whi...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/3327

    authors: Fink L,Seeger W,Ermert L,Hänze J,Stahl U,Grimminger F,Kummer W,Bohle RM

    更新日期:1998-11-01 00:00:00

  • Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells.

    abstract::We studied the effects of Lyn ablation on the survival of drug-resistant chronic myelogenous leukemia (CML) blast crisis cells using siRNA. Lyn siRNA reduced Lyn protein in both normal hematopoietic cells and BCR-ABL1-expressing (BCR-ABL1(+)) blasts by 80-95%. Within 48 h, siRNA-treated BCR-ABL1(+) blasts underwent ap...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1127

    authors: Ptasznik A,Nakata Y,Kalota A,Emerson SG,Gewirtz AM

    更新日期:2004-11-01 00:00:00

  • Somatic overgrowth associated with overexpression of insulin-like growth factor II.

    abstract::Overexpression of the normally imprinted fetal insulin-like growth factor II (IGF2) has been implicated in the pathogenesis of the cancer-predisposing Beckwith-Wiedemann syndrome (BWS). We have detected constitutional relaxation of imprinting of IGF2 in four children with somatic overgrowth who do not show diagnostic ...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm0396-311

    authors: Morison IM,Becroft DM,Taniguchi T,Woods CG,Reeve AE

    更新日期:1996-03-01 00:00:00

  • Cancer's true breakthroughs.

    abstract::A new regulatory pathway established last year allows drugs with dramatic early clinical promise to be expedited to the market quicker than ever before. To date, most of these 'breakthrough' designations have gone to cancer agents, raising the prospect of faster access to the latest lifesaving therapies for the estima...

    journal_title:Nature medicine

    pub_type: 新闻

    doi:10.1038/nm.3245

    authors: Dolgin E

    更新日期:2013-06-01 00:00:00

  • Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.

    abstract::While investigating the novel anticancer drug ecteinascidin 743 (Et743), a natural marine product isolated from the Caribbean sea squirt, we discovered a new cell-killing mechanism mediated by DNA nucleotide excision repair (NER). A cancer cell line selected for resistance to Et743 had chromosome alterations in a regi...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/91008

    authors: Takebayashi Y,Pourquier P,Zimonjic DB,Nakayama K,Emmert S,Ueda T,Urasaki Y,Kanzaki A,Akiyama SI,Popescu N,Kraemer KH,Pommier Y

    更新日期:2001-08-01 00:00:00

  • Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency.

    abstract::In the version of this article originally published, there was an error in the legend for Extended Data Fig. 7. The legend for panel f was originally: "f, FACS analysis of IL7R-, CD62L- and CD45RA- expression on TRAC-1928ζ and TRAC-1XX CAR T cells at day 63 post CAR infusion (representative for at least n = 3 mice per...

    journal_title:Nature medicine

    pub_type: 已发布勘误

    doi:10.1038/s41591-019-0360-3

    authors: Feucht J,Sun J,Eyquem J,Ho YJ,Zhao Z,Leibold J,Dobrin A,Cabriolu A,Hamieh M,Sadelain M

    更新日期:2019-03-01 00:00:00

  • The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy.

    abstract::Cancer-specific cell-surface antigens are ideal targets for monoclonal antibody (mAb)-based immunotherapy but are likely to have previously been identified in transcriptome or proteome analyses. Here, we show that the active conformer of an integrin can serve as a specific therapeutic target for multiple myeloma (MM)....

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm.4431

    authors: Hosen N,Matsunaga Y,Hasegawa K,Matsuno H,Nakamura Y,Makita M,Watanabe K,Yoshida M,Satoh K,Morimoto S,Fujiki F,Nakajima H,Nakata J,Nishida S,Tsuboi A,Oka Y,Manabe M,Ichihara H,Aoyama Y,Mugitani A,Nakao T,Hino M,

    更新日期:2017-12-01 00:00:00

  • A cannabinoid mechanism in relapse to cocaine seeking.

    abstract::Treatment of cocaine addiction is hampered by high rates of relapse even after prolonged drug abstinence. This relapse to compulsive cocaine use can be triggered by re-exposure to cocaine, by re-exposure to stimuli previously associated with cocaine or by exposure to stress. In laboratory rats, similar events reinstat...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1001-1151

    authors: De Vries TJ,Shaham Y,Homberg JR,Crombag H,Schuurman K,Dieben J,Vanderschuren LJ,Schoffelmeer AN

    更新日期:2001-10-01 00:00:00

  • rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

    abstract::Mice carrying mutations in both the dystrophin and utrophin genes die prematurely as a consequence of severe muscular dystrophy. Here, we show that intravascular administration of recombinant adeno-associated viral (rAAV) vectors carrying a microdystrophin gene restores expression of dystrophin in the respiratory, car...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1439

    authors: Gregorevic P,Allen JM,Minami E,Blankinship MJ,Haraguchi M,Meuse L,Finn E,Adams ME,Froehner SC,Murry CE,Chamberlain JS

    更新日期:2006-07-01 00:00:00

  • Fighting tobacco dependence in Europe.

    abstract::The World Health Organization estimates that tobacco will become the largest single health problem by 2020, causing an estimated 8.4 million deaths annually. But the smoking burden will not be distributed evenly across the globe; deaths in developed nations are set to rise 50% to 2.4 million while those in Asia will s...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/83281

    authors: Raw M

    更新日期:2001-01-01 00:00:00

  • Straight talk with...Ken Getz. [Interviewed by Cassandra Willyard].

    abstract::How should clinical trials be improved? Ken Getz, a senior fellow at the Tufts Center for the Study of Drug Development, has been thinking up answers to this question for two decades. In 2003, Getz took on a new challenge when he launched the Center for Information & Study on Clinical Research, a nonprofit focused on ...

    journal_title:Nature medicine

    pub_type: 面试

    doi:10.1038/nm0210-154

    authors: Getz K

    更新日期:2010-02-01 00:00:00

  • A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice.

    abstract::The balance between detrimental, pro-aging, often stochastic processes and counteracting homeostatic mechanisms largely determines the progression of aging. There is substantial evidence suggesting that the endocannabinoid system (ECS) is part of the latter system because it modulates the physiological processes under...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm.4311

    authors: Bilkei-Gorzo A,Albayram O,Draffehn A,Michel K,Piyanova A,Oppenheimer H,Dvir-Ginzberg M,Rácz I,Ulas T,Imbeault S,Bab I,Schultze JL,Zimmer A

    更新日期:2017-06-01 00:00:00

  • Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

    abstract::Immunodeficiency is a barrier to successful vaccination in individuals with cancer and chronic infection. We performed a randomized phase 1/2 study in lymphopenic individuals after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for myeloma. Combination immunotherapy consisting of a singl...

    journal_title:Nature medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/nm1310

    authors: Rapoport AP,Stadtmauer EA,Aqui N,Badros A,Cotte J,Chrisley L,Veloso E,Zheng Z,Westphal S,Mair R,Chi N,Ratterree B,Pochran MF,Natt S,Hinkle J,Sickles C,Sohal A,Ruehle K,Lynch C,Zhang L,Porter DL,Luger S,Guo C,

    更新日期:2005-11-01 00:00:00

  • v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.

    abstract::Matrix-producing osteoblasts and bone-resorbing osteoclasts maintain bone homeostasis. Osteoclasts are multinucleated, giant cells of hematopoietic origin formed by the fusion of mononuclear pre-osteoclasts derived from myeloid cells. Fusion-mediated giant cell formation is critical for osteoclast maturation; without ...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1514

    authors: Lee SH,Rho J,Jeong D,Sul JY,Kim T,Kim N,Kang JS,Miyamoto T,Suda T,Lee SK,Pignolo RJ,Koczon-Jaremko B,Lorenzo J,Choi Y

    更新日期:2006-12-01 00:00:00

  • Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.

    abstract::Oxidative damage from elevated production of reactive oxygen species (ROS) contributes to ischemia-reperfusion injury in myocardial infarction and stroke. The mechanism by which the increase in ROS occurs is not known, and it is unclear how this increase can be prevented. A wide variety of nitric oxide donors and S-ni...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm.3212

    authors: Chouchani ET,Methner C,Nadtochiy SM,Logan A,Pell VR,Ding S,James AM,Cochemé HM,Reinhold J,Lilley KS,Partridge L,Fearnley IM,Robinson AJ,Hartley RC,Smith RA,Krieg T,Brookes PS,Murphy MP

    更新日期:2013-06-01 00:00:00

  • Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts.

    abstract::It is estimated that 350 million individuals worldwide suffer from rare diseases, which are predominantly caused by mutation in a single gene1. The current molecular diagnostic rate is estimated at 50%, with whole-exome sequencing (WES) among the most successful approaches2-5. For patients in whom WES is uninformative...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/s41591-019-0457-8

    authors: Frésard L,Smail C,Ferraro NM,Teran NA,Li X,Smith KS,Bonner D,Kernohan KD,Marwaha S,Zappala Z,Balliu B,Davis JR,Liu B,Prybol CJ,Kohler JN,Zastrow DB,Reuter CM,Fisk DG,Grove ME,Davidson JM,Hartley T,Joshi R,Stro

    更新日期:2019-06-01 00:00:00

  • Simultaneous PET-MRI: a new approach for functional and morphological imaging.

    abstract::Noninvasive imaging at the molecular level is an emerging field in biomedical research. This paper introduces a new technology synergizing two leading imaging methodologies: positron emission tomography (PET) and magnetic resonance imaging (MRI). Although the value of PET lies in its high-sensitivity tracking of bioma...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1700

    authors: Judenhofer MS,Wehrl HF,Newport DF,Catana C,Siegel SB,Becker M,Thielscher A,Kneilling M,Lichy MP,Eichner M,Klingel K,Reischl G,Widmaier S,Röcken M,Nutt RE,Machulla HJ,Uludag K,Cherry SR,Claussen CD,Pichler BJ

    更新日期:2008-04-01 00:00:00

  • Vaccines: past, present and future.

    abstract::The vaccines developed over the first two hundred years since Jenner's lifetime have accomplished striking reductions of infection and disease wherever applied. Pasteur's early approaches to vaccine development, attenuation and inactivation, are even now the two poles of vaccine technology. Today, purification of micr...

    journal_title:Nature medicine

    pub_type: 历史文章,杂志文章

    doi:10.1038/nm1209

    authors: Plotkin SA

    更新日期:2005-04-01 00:00:00

  • Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.

    abstract::Relapse is the leading cause of mortality in children with acute lymphoblastic leukemia (ALL). Among chemotherapeutics, thiopurines are key drugs in ALL combination therapy. Using whole-exome sequencing, we identified relapse-specific mutations in the phosphoribosyl pyrophosphate synthetase 1 gene (PRPS1), which encod...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm.3840

    authors: Li B,Li H,Bai Y,Kirschner-Schwabe R,Yang JJ,Chen Y,Lu G,Tzoneva G,Ma X,Wu T,Li W,Lu H,Ding L,Liang H,Huang X,Yang M,Jin L,Kang H,Chen S,Du A,Shen S,Ding J,Chen H,Chen J,von Stackelberg A,Gu L,Zhang J,

    更新日期:2015-06-01 00:00:00

  • Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.

    abstract::Delayed T cell recovery and restricted T cell receptor (TCR) diversity after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are associated with increased risks of infection and cancer relapse. Technical challenges have limited faithful measurement of TCR diversity after allo-HSCT. Here we combined 5' r...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm.3100

    authors: van Heijst JW,Ceberio I,Lipuma LB,Samilo DW,Wasilewski GD,Gonzales AM,Nieves JL,van den Brink MR,Perales MA,Pamer EG

    更新日期:2013-03-01 00:00:00

  • Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial.

    abstract::The impact of single-agent antibodies against programmed death-ligand 1 (PD-L1) as maintenance therapy is unknown in patients with metastatic breast cancer. The SAFIR02-BREAST IMMUNO substudy included patients with human epidermal growth factor receptor type 2 (Her2)-negative metastatic breast cancer whose disease did...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/s41591-020-01189-2

    authors: Bachelot T,Filleron T,Bieche I,Arnedos M,Campone M,Dalenc F,Coussy F,Sablin MP,Debled M,Lefeuvre-Plesse C,Goncalves A,Reynier MM,Jacot W,You B,Barthelemy P,Verret B,Isambert N,Tchiknavorian X,Levy C,Thery JC,L'Har

    更新日期:2021-01-18 00:00:00

  • Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology.

    abstract::Phase 3 trials are the mainstay of drug development across medicine but have often not met expectations set by preceding phase 2 studies. A systematic meta-analysis evaluated all randomized controlled, double-blind trials investigating targeted disease-modifying anti-rheumatic drugs in rheumatoid and psoriatic arthrit...

    journal_title:Nature medicine

    pub_type: 杂志文章,meta分析

    doi:10.1038/s41591-020-0833-4

    authors: Kerschbaumer A,Smolen JS,Herkner H,Stefanova T,Chwala E,Aletaha D

    更新日期:2020-06-01 00:00:00

  • Identification of an endogenous inhibitor of prostatic carcinoma cell growth.

    abstract::The rate of expansion of primary prostatic carcinoma is comparatively slow, with tumours frequently taking years or decades to reach clinically relevant size. We now report the presence of an endogenous inhibitor, derived from aqueous extracts of human prostate tissue, which blocks prostatic carcinoma cell proliferati...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1095-1040

    authors: Smith RC,Litwin MS,Lu Y,Zetter BR

    更新日期:1995-10-01 00:00:00

  • Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network.

    abstract::Computerized electrocardiogram (ECG) interpretation plays a critical role in the clinical ECG workflow1. Widely available digital ECG data and the algorithmic paradigm of deep learning2 present an opportunity to substantially improve the accuracy and scalability of automated ECG analysis. However, a comprehensive eval...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/s41591-018-0268-3

    authors: Hannun AY,Rajpurkar P,Haghpanahi M,Tison GH,Bourn C,Turakhia MP,Ng AY

    更新日期:2019-01-01 00:00:00

  • Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.

    abstract::In the Supplementary Information originally published with this article, a lane was missing in the β-actin blot in Supplementary Fig. 2. The lane has been added. The error has been corrected in the Supplementary Information associated with this article. ...

    journal_title:Nature medicine

    pub_type: 已发布勘误

    doi:10.1038/s41591-018-0168-6

    authors: Wong GS,Zhou J,Bin Liu J,Wu Z,Xu X,Li T,Xu D,Schumacher SE,Puschhof J,McFarland J,Zou C,Dulak A,Henderson L,Xu P,O'Day E,Rendak R,Liao WL,Cecchi F,Hembrough T,Schwartz S,Szeto C,Rustgi AK,Wong KK,Diehl JA,

    更新日期:2018-10-01 00:00:00

  • Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo.

    abstract::Modest clinical outcomes of dendritic-cell (DC) vaccine trials call for the refinement of DC vaccine design. Although many potential antigens have been identified, development of methods to enhance antigen presentation by DCs has lagged. We have engineered a potent, drug-inducible CD40 (iCD40) receptor that permits te...

    journal_title:Nature medicine

    pub_type: 杂志文章

    doi:10.1038/nm1183

    authors: Hanks BA,Jiang J,Singh RA,Song W,Barry M,Huls MH,Slawin KM,Spencer DM

    更新日期:2005-02-01 00:00:00